Jun 18, 2013 - 9:46 pm
If it works on ovarian cancer...maybe it will work on UPSC which is said to be similar.
Excerpts from article:
Cancer breakthrough: New drug shown to prevent cancer growth ready for human testing
Researchers seek approval to start human testing
Two of the world's foremost cancer researchers announced Tuesday the creation of a new drug aimed at preventing the growth of an array of cancers.
Tak Mak, director of the Campbell Family Institute for Breast Cancer Research at the Princess Margaret Cancer Centre, and Dr. Dennis Slamon, of the University of California, Los Angeles, are part of the 100-person team that developed the drug, which has been tested on human ovarian, breast, pancreas, lung and colon cancer in mice.
The researchers are calling the drug a "sharpshooter" for its ability to target a specific enzyme, rather than take a "one-size-fits-all" approach, Slamon explained to reporters at a Toronto news conference.
Developed by an international team of researchers, the new drug, called CFI-400945, has so far cost $40 million to produce. It was funded by donations.
A 4,000-page application to the U.S. Food and Drug Administration was filed in April and a submission to Health Canada was made Monday. The team hopes to begin testing the drug on humans in clinical trials later this year.
The initial reaction from the FDA was "favourable," Mak said, noting it made some suggestions that are to be reviewed.
Mak said the drug responded "spectacularly" when tested on human breast and ovarian cancer in mice.